All Rights Reserved. Forward ® 2018

EBD Group Inc., 3150 Pio Pico Drive, Suite 201, Carlsbad, CA, 92008



Tuesday, January 8, 4:30-5:15 pm
Hilton San Francisco Union Square

It used to be that patient groups were involved at the beginning (advocating for research) and the end (demanding access) of drug discovery and development. Today – enabled by the emergence of and access to new technologies and spurred on by the shortcomings of traditional drug discovery and development – rare disease communities are aggregating data, establishing collaborative research networks and nimble partnerships with industry. Even creating companies to accelerate the speed and enhance the productivity of drug discovery.  Hear about who and what’s behind these models, and implications even beyond rare disease, in particular for investors, from expert stakeholders in a stand-and-deliver format that will keep you energized and engaged.

UPGRADE TO A FULL REGISTRATION:

  • Biotech Showcase™ 
  • One-to-one meetings in partneringONE®
  • Two and a half days of digital medicine and medtech programming
  • 70 curated digital medicine and medtech company presentations
  • Specialized sessions
  • Networking opportunities
Find out more!

The Shifting Model – How new era, patient-led collaborations are transforming drug discovery and development in rare disease, and beyond.

January 7–9, 2019
HILTON SAN FRANCISCO UNION SQUARE,
San Francisco, CA 94102 USA

Presented by:

This session is now at capacity and any RSVPs after 1.3.2019 are subject to seating availability on the day of. Please arrive early to secure a seat. 

Presented by: